New drug shows promise in treating indolent non-Hodgkin lymphomas

(Fred Hutchinson Cancer Research Center) A new drug, idelalisib, showed promise in a phase 2 study for treating patients with indolent non-Hodgkin lymphoma.

Source: EurekAlert! - Cancer - January 22, 2014 Category: Cancer & Oncology Source Type: news